Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer

Clinical trial NCT05062980 · TERMINATED

Trial details

NCT number: NCT05062980
Sponsor: Genprex, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2022-03-30
Primary completion: 2025-02-03
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.